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ABSTRACT
Meningoencephalitis is a syndrome of multiple etiologies associated with important 
morbidity and mortality. It may be caused by various infectious agents (viruses, bacteria, 
parasites and fungi). Establishing the etiology of meningoencephalitis is crucial for 
early and specific treatment. Molecular assays such as the multiplex polymerase chain 
reaction (PCR) offer an alternative in diagnosing central nervous system infections. This 
study aimed to describe the performance of an automated multiplex molecular test from 
patients with suspected meningitis and meningoencephalitis in a tertiary referral complex 
in Medellin, Colombia. Thus, a prospective study was performed in 638 cerebrospinal 
fluid samples from January 2017 to July 2019. Molecular detections were carried out by 
means of the FilmArray® Meningitis/Encephalitis (M/E) Panel from bioMérieux, France, 
and by  conventional tests. Univariate analyses for microbiological and demographic 
characteristics were performed. Accuracy of the bacterial/fungal PCR assay compared to 
cultures was also performed. Among patients, 57.7% were male, the median age was 24 
(IQR: 6 - 47) years old. The overall positivity was 15.2% (97 detections) and viruses were 
detected in 45.5% of the samples, bacteria in 43.5% and fungi in 10.8%. The most frequent 
etiological agents were: Streptococcus pneumoniae (16%), Cryptococcus neoformans/gatti 
(11.3%) and Herpes simplex virus (10.3%). Four double detections were found. Almost 
half of positive detections were in patients under 15 years old. This molecular approach 
is reliable and easily implantable into a laboratory routine, increasing the capacity of 
detection of bacterial and viral causative agents of meningitis, possibly playing a relevant 
role in the clinical context.
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INTRODUCTION
Meningitis is an inflammatory condition involving the membranes covering the 
central nervous system (CNS) that can be caused by bacteria, viruses, parasites and 
fungi1. According to the Global Burden of Diseases study, in 2016 there number 
of incident cases were estimated at 2.82 million while the number of meningitis 
deaths were estimated at 318,400 cases. Most deaths occurred in countries of low 
sociodemographic index as the ones in sub-Saharan Africa, in which the incident 
cases are the highest, 207.4 per 100,000 inhabitants2. In the United States, every 
year approximately 4,100 cases of bacterial meningitis are diagnosed leading to 
500 deaths. On the other hand, viral etiology is more common in patients under 
15 years old, with 20,000 cases and an average of 1,400 deaths per year1,3. 
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In Colombia, historical incident cases of bacterial 
meningitis are in the range of 0.06-0.28 per 100,000 
inhabitants for Haemophilus influenzae, Streptococcus 
pneumoniae and Neisseria meningitis, with a lethality rate 
between 3.5-21%4. Data from the Laboratory surveillance 
SIREVA network, in Latin America and the Caribbean 
showed that S. pneumoniae serotype 14 was the most 
frequently isolated (21.1%), especially in children under 
6 years of age (29.1%). Regarding the viral etiology, until 
today, the magnitude of the problem is unknown due to 
the underreporting of cases to the public epidemiological 
surveillance system. 
In Colombia, during 2004, an epidemic of aseptic 
meningitis was registered in Antioquia, with a total of 263 
reported cases, 77% of them (160/263) in Medellin, and 
the National Institute of Health demonstrated that four of 
them were caused by Echoviruses 305.
From the Public Health point of view, rapid diagnosis 
and treatment of CNS infections are crucial to impact 
the morbidity and mortality. In addition, in many areas 
around the world, particularly in rural areas, the capacity 
to perform traditional diagnostic assays, such as culture 
or the detection of bacterial antigens is limited or non-
existent, leading to delayed or absence of the etiological 
diagnosis2. Traditionally, laboratory diagnosis of meningitis 
have included examination of cerebrospinal fluid (CSF) 
specimens for cells count, measurement of glucose and 
protein levels, and the gram staining; these tests may suggest 
the type of infection but they are not specific. Bacterial 
cultures from CSF can provide the diagnosis, however, it 
may take several days and it has critical limitations such as 
the sensitivity to detect some pathogens1. Regarding viral 
detection, before the development of molecular methods 
such as Polymerase Chain Reaction (PCR), the isolation 
of pathogens traditionally relied on cell culture, despite the 
long period required to release the result, aside from the 
need of technical expertise6.
Recently, molecular tests allowing a syndromic approach 
to diagnosis of meningitis have become available in 
Colombia, such as the FilmArray® Meningitis/Encephalitis 
(FA-M/E) panel (BioFire Diagnostics, bioMérieux, Salt 
Lake City, USA). This is a molecular tool that allows the 
simultaneous detection of 14 pathogens (bacteria, viruses 
and one fungus). The entire process is fully automated and 
takes approximately one hour to release the results7. In this 
study, we have documented the performance of FA-M/E 
in CSF samples of patients with suspected meningitis or 
meningoencephalitis infections in the context of a tertiary 
referral hospital, comparing the results obtained by this 
molecular method with traditional testing. 
MATERIALS AND METHODS
Study design
A prospective study of consecutive samples from 
638 patients with clinical suspicion of neuroinfections 
was conducted between January 2017 to July 2019 in the 
teaching Hospital San Vicente Fundacion in Medellin, 
the second largest city of Colombia. It is a tertiary health 
institute and a reference center for infectious diseases, with 
a total of 819 beds of capacity. 
The criteria for suspect meningitis infection and the 
inclusion of the patients followed the institutional clinical 
guideline, with findings such as headache, nuchal rigidity, 
fever and altered consciousness4. The patients must have 
molecular and microbiological tests requested by the 
attending physician and there was no age restriction.
Clinical and epidemiologic information
Clinical, microbiological and demographic information 
were obtained from the electronic medical records and from 
the laboratory database of the hospital. The studied variables 




CSF samples were collected in three sterile tubes 
(1-3 mL), which were used for the biochemical analysis, 
as well as microbiological and molecular tests.
Cellular and chemical parameters
Total protein and glucose, was determined by benze-
thonium cholire and hexokinase/G-6-PDH, respectively 
(Architect, Abbott, IL, USA); the total White Blood Cell 
(WBC)/ mm3 was quantified in non-centrifuged CSF using 
a Neubauer chamber.
Gram staining
After centrifugation (1,300 g for 10 min), the smear 
was prepared by placing 1-2 drops of the sediment on a 
glass slide, air-dried, and subsequently, Gram-stained by 
PREVI® Color Gram (bioMerieux, Inc., Durham, NC, 
USA), following the instructions of the manufacturer.
Bacterial/fungal culture
Bacterial cultures were performed on every collected 
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specimen using the laboratory standard procedures. Solid 
media (blood, chocolate, and Sauboraud agar) and a 
thioglycolate broth were incubated at 37 °C in 5% CO2 for 
5 d. Microbial isolates were identified by a matrix-assisted 
laser desorption ionization–time of flight mass spectroscopy 
(MALDI-TOF MS) analysis. In addition, a lateral flow assay 
for a cryptococcal antigen (CrAg) was performed in patients 
with suspicion of fungal disease in the CNS. 
Molecular test
The FA-M/E was performed in accordance with the 
manufacturer’s instructions. Briefly, a total of 200 µL of 
each CSF sample were required to run the assay; the test 
process includes a nucleic acid extraction/purification 
stage, a first round of highly multiplexed amplification of 
all targets, followed by a nested-amplification of each target 
triplicated tested on the array. The FilmArray® software 
system automatically interprets the three results obtained 
as three independent melting curves to give a unique final 
result7. The master list includes: E. coli K1, H. influenzae, 
L.monocytogenes, N. meningitidis, S.agalactiae, S. 
pneumoniae, CMV (Cytomegalovirus), EV (Enterovirus), 
Herpes Simplex Virus 1 and 2 (HSV-1 and HSV-2), Human 
Herpes virus 6 (HHV-6), Human Parechovirus (HPeV), 
Varicella-Zoster Virus (VZV) and C. neoformans/gatti.
Date analysis
All data were entered into a Microsoft Office Excel 
2016 database. Statistical analysis was performed using R 
(version 3.6.3, The R Foundation for Statistical Computing, 
Vienna, Austria). Demographic data are presented as 
descriptive statistics. Sensitivity and Specificity values 
were calculated in a 95% confidence interval (CI) for 
bacterial and fungi detections, using CSF culture as the 
reference (standard) with Epidat (version 4.2, Conselleria 
de Sanidade, Xunta de Galicia, Spain). Nonparametric 
Kruskal-Wallis test was used to compare the differences 
between cellular/chemical parameters (CSF cells count, 
protein levels and glucose) and FA-M/E (bacterial, fungal 
and viral detections); results were considered statistically 
significant at p < 0.05. 
Ethical considerations
The ethical approval was obtained from the institutional 
review committee according to the technical-administrative 
procedures for health research included in the resolution 
N° 8430 of the Ministry of Health of Colombia8. 
Additionally, this study complied with the World Medical 
Association Declaration of Helsinki regarding the ethical 
conducts of research involving human subjects.
RESULTS
A total of 695 consecutive samples were included in the 
study, and 57 were excluded due to inconsistencies in culture 
results or in cellular and chemical parameters. In addition, 
during the study period, 11 samples were unsuccessful due 
to flaws in the internal pouch control, but were reprocessed. 
A total of 638 samples met all enrollment criteria, and were 
analyzed. Among the patients, 83.4% (362) were male, the 
median age was 24 years (IQR: 6-47), ranging from one 
day to 87 years old; the most common comorbidities were 
CNS-associated diseases, while the second most frequent 
comorbidity was HIV infection, but only 250 patients were 
subjected to the HIV test (HIV antibodies detection or viral 
load). Other characteristics of patients are shown in Table 1. 
The overall positivity of the multiplex test was 15.2% 
(97 detections), and Streptococcus pneumoniae was the most 
frequent pathogen with 16.5% (16); among viruses Herpes 
simplex 1 was the most commonly detected. Four samples 
presented double detections (Table 2). Around 50% of 
detections were in patients under 15 years old. In this group, 
the most commonly detected organisms were HHV-6 and 
Neisseria meningitidis. Among those aged 25 or older, C. 
neoformans/gatti and S. pneumoniae were the predominant 
pathogens (Figure 1). The 97 positive detections according 
Table 1 - Demographic and clinical characteristics of patients 
with suspected meningitis and meningoencephalitis, Hospital 
Universitario San Vicente Fundacion, Medellin, 2017-2019
Characteristicss





< 1 58 9.1
1 a 14 184 28.8
15 a 35 170 26.6
36 a 64 162 25.4
> 65 64 10.0
Comorbidity
Associated to CNS 395 619
HIV infection 50 7.8
Sepsis 27 4.2
CNS = Central Nervous System; HIV = Human Immunodeficiency 
Virus
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Table 2 - Detected pathogens by Biofire® FilmArray® Meningitis/Encephalitis, Hospital Universitario San Vicente Fundacion, 
Medellin, 2017-2019.
















S. agalactiae + E. coli K1
Enterovirus + HHV 6






































Virus = 45,5%; Bacteria = 43,5%; Fungi = 10,8%
Figure 1 - Distribution of pathogens detected by the Biofire® FilmArray® Meningitis/Encephalitis according to the age groups (years), 
Hospital Universitario San Vicente Fundacion, Medellin, 2017-2019.
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to the HIV status were: 55% (54) in HIV-negative patients, 
19.5% (19) in HIV-positive ones, while in the remaining 
24% (24) of the patients, the HIV status was not evaluated. 
C. neoformans/gatti (8), VZV (4), CMV (3) were most 
frequently detected in HIV-positive patients. 
When the cellular and chemical parameters between 
positive and negative detections were compared, most 
positive patients had an increased CSF protein and WBC 
levels, the median of WBC count and proteins levels were 41 
(0-369) cells/mm3 and 102.9 (46-214) mg/dL respectively, 
while in negative patients the same parameters were 1 
(0-18) cells/mm3 and 34 (23.1-76.6) mg/dL, respectively. 
Regarding the positive detections, the differences between 
bacterial, fungal and viral detections are shown in Table 3. 
There was a total agreement for the 11 detections of 
C. neoformans/gatii between FA-M/E and CrAg, however, 
four positive results with CrAg were negative by FA-M/E.
Culture methods detected microorganisms that are not 
included in the FA-M/E master list, such as Staphylococcus 
aureus (2), Staphylococcus epidermidis (2), Staphylococcus 
capitis (2), Elizabethkingia meningoseptica, Streptococcus 
mitis/oralis. To determine the sensitivity of the test, these 
organisms were excluded. The operational characteristics 
of the molecular test are shown in Table 4. The average 
turnaround time for FA-M/E in the laboratory was 4.5 h, 
due to administrative procedures.
DISCUSSION
The novel FA-M/E technique represents a milestone in 
clinical practice, as its clinical significance in diagnosing 
meningitis etiology in the Colombian population is still 
unknown due to its sparse use. However, its implementation 
constitutes a great opportunity to optimize the turnaround 
time to release results and to provide novel contributions 
to the knowledge of meningitis in our country and in Latin 
America. 
In the present study, the male gender was more frequent 
and the positivity in this group was 64.9% (63/97), and it is 
important to note that meningitis in male differs significantly 
from the ones in females with respect to comorbidities and 
predictors of adverse clinical outcomes9. In addition, it is 
recognized that men have an increased susceptibility to 
several pathogens10. 
The global positivity of the test was 15.2%, with nearly 
equal proportions of bacteria and viruses detected by 
FA-M/E, contrasting with previous studies in which viruses 
were the most frequent, corresponding to around 80% of 
detections11-14. This could be explained by differences in 
the studies designs, such as patients’ selection criteria, 
specific population defined by age or clinical condition, 
antimicrobial therapy, the country’s socioeconomic and 
epidemiological conditions, but even so, the proportion of 
positive cases found in the present study is in agreement 
with previous reports, varying from 12-14%11,15. 
The most prevalent microorganisms detected during this 
study were S. pneumoniae, C. neoformans/gatti and HSV-1, 
in 16.6%, 11.3%, 10.3% respectively. By bacterial analytes, 
S. pneumoniae was the most frequent microorganism 
isolated; this finding agrees with published studies 
with similar number of samples11-15. H. influenzae was 





Bacterial (n = 40) Fungal (n = 11) Viral (n = 42)
CSF parametersb
Protein (mg/dL) 196.8 (53.1 – 400) 63.5 (32.1 – 188) 75 (36.8 – 138) 0.01
Glucose (mg/dL) 19.5 (4 – 44.7) 34 (11 – 42) 51 (42 – 72) 0,00
White blood cells (mm3) 169 (4.2 – 1,177) 15 (2.25 – 276.5) 9 (0 -236) 0.03
Polymorphonuclear (mm3) 75 (0.2 – 1,692) 12 (1.5 – 200) 3 (0 – 82.5) 0.02
Mononuclear (mm3) 22.5 (0 – 79.5) 3.5 (0.5 – 102) 0 (0 – 30.5) 0.06
Double detections were not included (4); aKruskal-Wallis test; bMedian (Rq)
Table 4 - Analytical performance of the Biofire® FilmArray® ME 






+ 21 33 54
- 3 581 585
Total 24 614 638
Sensitivity = 87.50 (IC 95%: 72.19 - 100.00); Specificity = 94.63 
(IC 95%: 92.76-96.49); Positive predictive value = 38.89 
(IC 95%: 24.96-52.82); Negative predictive value = 99.49 
(IC 95%: 98.82-100.00)
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detected in different age groups despite being a common 
cause of meningitis in childhood and thewidespread 
vaccination, which has significantly reduced the incidence 
of H. influenza infections in many low and middle income 
countries, including Colombia4,16. On the contrary, N. 
meningidis was mainly detected in patients younger than 
14 years old (7 cases), although all age groups are at risk 
of invasive meningococcal disease, infants are particularly 
vulnerable due to the disappearance of passively transferred 
maternal antibodies17. Other bacteria were less frequently 
detected, such as L. monocitogenes, found in three adults 
with CSF-negative culture. In one of the three cases, 
L. monocitogenes was isolated in a blood cultureprobably 
due to an early hematogen dissemination that probably took 
place before the meningeal invasion, a process that has been 
previously described18. It is known that L. monocytogenes 
has become the third most frequent pathogen of bacterial 
meningitis in adults after the vaccination era19.
In a multicenter prospective study that used FA-M/E, 
the overall sensitivity was 85.7% (HHV-6), 95.7% (EV) 
and 100% for the remaining pathogens; the specificity was 
above 99 % for all the 14 pathogens13. In the present study, 
for bacterial and fungal analytes, the general sensitivity 
and specificity were 87.5 (95% CI: 72.1 - 100 %) and 94.7 
(95% CI: 92.9 -96.6 %), respectively findings are in line 
with previous publications that shown values between 
60 to 100% of sensitivity by individual target13,20. In this 
study, CSF cultures were positive in 44.4% (24/54) of the 
cases positive by FA-M/E (bacteria/fungi). Disagreements 
between the molecular detection and cultures results 
may have been due to limitations in the conventional 
microbiology as a reference method or if antibiotics have 
been administered prior to the lumbar puncture1,6. FA-M/E 
has shown to be efficient in detecting bacteria involved 
in meningitis cases in which CSF culture was negative12. 
On the other hand, negative results can be useful in the 
differential diagnosis. According to a systematic review, 
the negative predictive value of FA-M/E has almost 99% 
possibility of being correct21.
Regarding viral detections, this is the first time that they 
were routinely performed in clinical practice in this hospital. 
HSV-1, VZV and HHV-6, with 10, 8, 8 cases, respectively, 
were the most frequent viral pathogens in a wide range of 
age. Latency and reactivation are characteristics of viruses 
from the herpes family, including HSV-2/CMV and they 
can affect both genders and all age groups, including 
immunosuppressed patients22. Seven cases of HHV-6 were 
detected in patients under 5 years old, and it is known that 
around 20% of emerging room consultations in children 
are attributable to HHV-623. Other FA-M/E studies detected 
HHV-6 among 1.9 – 2.7%13,24. CMV was detected in 
four cases, and the reliability of these positive findings in 
FA-M/E is unclear, especially in CMV-seropositive patients 
indicating a past infection or passive transfer of maternal 
antibodies to infants25. An important limitation of FA-M/E 
is that it does not distinguish latent/active CMV and HHV-6 
infections, therefore, clinical information are important 
for the interpretation of results. Regarding EV detections, 
they were more frequent in patients under 6-years old, and 
it has been reported that the majority of aseptic meningitis 
cases occurred mainly in those under one-year old26.  Other 
viruses are present in low frequencies, highlighting the 
possibility to report new cases that have not been previously 
described in the region, such as the HPeV, which belongs 
to the Picornaviridae family and rarely causes meningitis 
or meningoencephalitis27. In this study, it was detected in 
one case, in a 48-year-old male. 
Concerning fungi detections (11 detections), there was 
not a significant contribution due to a complete agreement of 
FA-M/E with CrAg, which has been reported in the literature 
with a sensitivity and specificity around 93-100%28. 
However, in present study, there were disagreements due 
to four positive samples by CrAg that were negative by 
FA-M/E, as has been previously reported. The explanation 
for this finding is that the patient can remain positive for 
years, even after the resolution of the infection28,29. A 100% 
sensitivity of FA-M/E for newly diagnosed cryptococcosis 
in an HIV-infected population has been reported30.
False negative results for viral targets, were not 
evaluated as there was not an available comparative testing, 
however, false-negative FA-M/E results have already been 
reported with respect to several viruses such as EV, HSV-1, 
HSV-2, VZV and HHV-613,14 culture, antigen detection, 
and molecular methods, paired with chemical and cellular 
analyses. These methods may lack sensitivity or specificity, 
can take several days, and require significant volume for 
complete analysis. The FilmArray Meningitis/Encephalitis 
(ME. A viral load close to the limit of detection and errors 
caused by incorrect interpretation of the algorithm of the 
instrument, have been documented30. 
In present study, the bacterial/fungal detections 
presented three false-negative results (S. agalactiae, E. coli 
and C. neoforman/gatiii), and similar findings have been 
previously described15,20,29,30. Factors such as low antigens 
titers, high PCR crossing thresholds and cultures with 
growth < 100 CFU/mL are associated with disagreements 
that can be attributed to reagents degradation in a kit near 
to expiration date low fluorescence and incorrect melting 
signals29,31. The trueness analysis of results among all 
positive detections was not performed, and false positives 
are a possible scenario, fact that has been previously 
reported to CMV. In the presence of a bacterial meningitis, 
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false positives may be related to the latency of WBC in 
immunocompetent patients32, likewise, in bacterial/fungal 
detections, false positives may occur due to a number 
of reasons such as: CSF samples containing low levels 
of microorganisms that are undetectable in cultures, 
low pathogens concentration due to earlier antibiotic 
administration, and the fact that FA-M/E can detect unviable 
bacteria/fungi1,6. Particularly, two studies reported the 
highest proportion of false positive results to S. pneumoniae 
(17.5 and 80%)13,21, and in the present study, there were 16 
detections of S. pneumoniae, of which six were negative in 
cultures, and clinical correlations showed that only four of 
them had a high level of bacterial meningitis suspicion. A 
positive result should be analyzed carefully and correlated 
with the medical chart data; repeating the test may be 
helpful, but a repeated negative result may not necessarily 
rule out an initial positive result in cases of low pathogen 
loads33,34 other panels have been approved by the FDA, and 
most recently, the FilmArray meningitis/encephalitis panel 
(BioFire, Salt Lake City, UT. 
In this study, other microorganisms not included in 
the FA-M/E master list were detected by cultures and it 
should be noted that molecular assays should be interpreted 
according to local epidemiology, for example, Klebsiella sp, 
M. tuberculosis, S. epidermidis are not frequently associated 
with meningitis, but they can be causative agents of 
meningitis in individuals with some risk factors1,4,9. Another 
aspect to be considered, was the four double detections; even 
if they may look an advantage, their clinical significance are 
not clearly understood and require more studies; however, 
previous reports suggested that reactivations during acute 
meningitis by other microorganisms can occur34,35. 
This study has certain limitations, firstly, with respect 
to viral detections, a suitable comparative marker was not 
available. Despite this fact, the majority of positive cases 
were taken into account for the patient’s management. 
Secondly, the low number of positive samples to each of 
the bacterial microorganisms do not allow an adequate 
statistical power to evaluate the sensitivity of FA-M/A; 
additionally, antibiotic administration was not considered 
in the study variables, therefore, the general impact of 
antibiotic use on the positivity of the test can be limited. 
Moreover, other risk factors such as pregnancy, the use of 
immunosuppressive drugs and further comorbidities were 
not evaluated. Thirdly, no sample randomization was done 
as samples were included consecutively. Nevertheless, this 
is the largest study in the country that included a significant 
sample size and a long evaluation period. 
As the main contribution, this study has a significant 
proportion of cases (33 detections) that were detected and 
are not in general diagnosed by traditional tests. Likewise, 
viral detection was overwhelming, as in the institution in 
which the study was performed, traditionally viruses are 
diagnosed by external laboratories, with low sensitivity of 
methods and prolonged turnaround time, and without the 
FA-M/E diagnoses might have been delayed or missed. 
Compared to culture or conventional PCR assays (one 
pathogen by test), FA-M/E is very faster, which makes it 
ideal to be introduced in a laboratory routine. In clinical 
practice, it is often necessary to identify multiple pathogens 
that may be associated with a certain infectious syndrome. 
The possibility of detecting multiple targets in a single 
sample is important when clinical samples are difficult 
to collect, or are limited in volume, or when different 
pathogens can cause the same clinical presentation, which 
poses a greater difficulty to the diagnosis. In addition, 
the cost versus effectiveness of the test compared to the 
testing of each pathogen separately is also an advantage 
of the FA-M/E 
In conclusion, the FA-M/E system is able to detect a 
broad range of pathogens directly in CSF samples with 
good performance parameters when compared to reference 
methods, as it has the great advantage of requiring little 
preparation and handling of the samples. 
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